Latest News
News
Which factors distinguish superagers from the rest of us?
The superagers indicated that generally they had been more active than the control subjects during their middle years.
Latest News
New COVID shots will be available in September
“We are likely to see this as a recommendation as an annual COVID shot, just as we have an annual flu shot.”
Latest News
Children and long COVID: How many are affected?
A warning sign of long COVID in children is profound fatigue.
Latest News
Long COVID–induced activity limitations persist
The prevalence of long COVID in the United States has remained stable, as has the proportion of patients reporting significantly reduced function...
Latest News
It may be time to pay attention to COVID again
While the numbers are still low, compared with 2022’s summer surge, experts still urge people to stay aware of changes in the virus. “I do not...
Latest News
U.S. has new dominant COVID variant called EG.5
Called “Eris” among avid COVID trackers, the strain EG.5 now accounts for 17% of all U.S. COVID infections.
Latest News
Depression at any stage of life tied to increased dementia risk
The double risk persists regardless of when in life depression is diagnosed.
Latest News
Medicare to pay for at-home dementia care coordination
The program is voluntary and will be open to Medicare-enrolled clinicians and other providers who can assemble an interdisciplinary care team and...
Latest News
Multiple trials of long COVID treatments advancing, more on the way
The new clinical trials are in phase 2 and will test safety and effectiveness.
Latest News
Off-label meds: Promising long COVID treatments?
Low-dose naltrexone is a major topic of discussion on public long COVID patient groups on Facebook.